Frank Lupisella - C R Insider

BCR -- USA Stock  

null 331.24  0.00  0.00%

Principal Accounting Officer, VP and Controller

Mr. Frank Lupisella Jr., is Vice President, Controller of the Company. Mr. Lupisella joined Bard in 1987 and has served in various capacities in the finance organization of the company. Mr. Lupisella served as Vice President and Controller of the Davol division from 1999 until 2005 when he was promoted to Assistant Corporationrationrate Controller, Manufacturing Operations. In 2006, he was promoted to his present position of Vice President and Controller of the company.
Age: 55  VP Since 2006      
908 277-8000

Frank Lupisella Latest Insider Activity

Management Efficiency

The company has Return on Asset of 11.65 % which means that on every $100 spent on asset it made $11.65 of profit. This is considered to be average in the sector. In the same way, it shows return on shareholders equity (ROE) of 30.56 % implying that it generated $30.56 on every 100 dollars invested.
The company has 1.64 B in debt with debt to equity (D/E) ratio of 81.4 . This implies that the company may be unable to create cash to meet all of its financial commitments. C R Bard has Current Ratio of 1.69 which is typical for the industry and considered as normal.

Similar Executives

Found 10 records

VP Since

Larry WoodEdwards Lifesciences Corporatio
Jeanne MasonBaxter International
Sebastian BufalinoBaxter International
Patrick VerguetEdwards Lifesciences Corporatio
Timothy LawrenceBaxter International
John GallagherBecton Dickinson and Company
Dennis MagulickGNC Holdings
Michael UllmannJohnson Johnson
David ScharfBaxter International
Donald BoboEdwards Lifesciences Corporatio

Entity Summary

C. R. Bard, Inc., together with its subsidiaries, designs, manufactures, packages, distributes, and sells medical, surgical, diagnostic, and patient care devices worldwide. C R Bard (BCR) is traded on New York Stock Exchange in USA. It is located in NEW JERSEY, U.S.A and employs 14,900 people. C R is listed under Medical Equipment category by Fama And French industry classification.

C R Bard Leadership Team

James Beasley, President
Patricia Christian, President
Sharon Alterio, President
Todd Garner, President
Marc Breslawsky, Director
John Weiland, President, MBA
John DeFord, President
Frank Lupisella, VP
Betty Larson, President
John Groetelaars, President
Tony White, Director
Gerard Porreca, President
Robert Davis, Director, MBA
Anthony Welters, Director
Gail Naughton, Director, MBA
John Kelly, Director, MBA
Tommy Thompson, Director
Samrat Khichi, President
Sharon Luboff, President
Herbert Henkel, Director, MBA
Christopher Holland, CFO
David Melcher, Director
Jim Beasley, Executive
Timothy Collins, Executive
Timothy Ring, Chairman
David Barrett, Director

Stock Performance Indicators

Did you try this?

Run Cryptocurrency Arbitrage Now

Cryptocurrency Arbitrage

Find pairs of digital assets on multiple exchanges that are traded at a risk free arbitrage
All  Next Launch Cryptocurrency Arbitrage

Pair Correlation

Equities Pair Trading Analysis
Correlation analysis and pair trading evaluation for C R and Edwards Lifesciences. Pair trading can be used as a hedging technique within a particular sector or industry or even over random equities to generate better risk-adjusted return
Run Pair Correlation  
Check also Trending Equities. Please also try Balance Of Power module to check stock momentum by analyzing balance of power indicator and other technical ratios.